Texas 2019 86th Regular

Texas House Bill HB2050 Comm Sub / Bill

Filed 04/17/2019

                    86R24163 EAS-F
 By: Paddie H.B. No. 2050
 Substitute the following for H.B. No. 2050:
 By:  Klick C.S.H.B. No. 2050


 A BILL TO BE ENTITLED
 AN ACT
 relating to consent requirements for the prescription of certain
 psychoactive medications to residents of nursing facilities and
 related institutions.
 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
 SECTION 1.  Section 242.505, Health and Safety Code, is
 amended by amending Subsection (c) and adding Subsection (c-1) to
 read as follows:
 (c)  Subject to Subsection (c-1), consent [Consent] to the
 prescription of psychoactive medication given by a resident or by a
 person authorized by law to consent on behalf of the resident is
 valid only if:
 (1)  the consent is given voluntarily and without
 coercive or undue influence;
 (2)  the person prescribing the medication or that
 person's designee provided the following information, in a standard
 format approved by the department, to the resident and, if
 applicable, to the person authorized by law to consent on behalf of
 the resident:
 (A)  the specific condition to be treated;
 (B)  the beneficial effects on that condition
 expected from the medication;
 (C)  the probable clinically significant side
 effects and risks associated with the medication; and
 (D)  the proposed course of the medication;
 (3)  the resident and, if appropriate, the person
 authorized by law to consent on behalf of the resident are informed
 in writing that consent may be revoked; and
 (4)  the consent is evidenced in the resident's
 clinical record by:
 (A)  a signed form prescribed by the facility or
 by a statement of the person prescribing the medication or that
 person's designee that documents that consent was given by the
 appropriate person and the circumstances under which the consent
 was obtained; and
 (B)  the original or a copy of the written consent
 required by Subsection (c-1), if applicable.
 (c-1)  In addition to the requirements of Subsection (c),
 consent to the prescription of an antipsychotic or neuroleptic
 medication is valid only if the consent to the prescription of that
 medication is given in writing, on a form prescribed by the
 department, by a resident or by a person authorized by law to
 consent on behalf of the resident.
 SECTION 2.  This Act takes effect September 1, 2019.